Full-Body scan may spot hidden inflammation and heart danger
NCT ID NCT07258524
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a special full-body PET scan can more accurately detect active ANCA-associated vasculitis (AAV) and predict long-term heart disease risk. Researchers will scan up to 120 participants (some with active AAV, some healthy) using three different tracers and compare results with standard tests. The goal is to find a non-invasive tool that improves diagnosis and management of this serious autoimmune condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANCA ASSOCIATED VASCULITIS (AAV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Edinburgh
RECRUITINGEdinburgh, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted antibody tame kidney inflammation without heavy steroids?
- New mRNA injection aims to tame autoimmune diseases
- Engineered immune cells take on lupus and scleroderma in early trial
- Can early rituximab stop vasculitis relapses? new study aims to find out
- Experimental cell infusion aims to tame childhood autoimmune diseases
- Immune reset: CAR-T therapy targets lupus, MS, and more